Latest News

May 10, 2021
Lytix Biopharma announces positive Phase I data for LTX-315
Apr 13, 2021
Lytix Biopharma decides to initiate a process of raising capital
Mar 29, 2021
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway for a class of new drug candidates - and forms a strategic partnership with the US-based Aurelius Biotherapeutics
Mar 1, 2021
Lytix Biopharma has appointed Gry Stensrud as Chief Technology Officer